25612-46-8 Usage
Description
Lysinonorleucine, a derivative of the amino acid lysine, is an off-white solid with unique chemical properties. It is known for its potential applications in the medical field, particularly in the treatment of various types of tumors.
Uses
Used in Pharmaceutical Industry:
Lysinonorleucine is used as a therapeutic agent for the treatment of malignant and benign tumors. Its chemical structure allows it to interact with specific biological targets, making it a promising candidate for cancer treatment.
Used in Cancer Treatment:
Lysinonorleucine is used as an anti-cancer agent, targeting both malignant and benign tumors. Its specific interactions with biological molecules contribute to its effectiveness in inhibiting tumor growth and progression, offering a potential alternative or complementary approach to conventional cancer therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 25612-46-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,1 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 25612-46:
(7*2)+(6*5)+(5*6)+(4*1)+(3*2)+(2*4)+(1*6)=98
98 % 10 = 8
So 25612-46-8 is a valid CAS Registry Number.
25612-46-8Relevant articles and documents
Synthesis of reduced collagen crosslinks
Van den Nieuwendijk, Adrianus M.C.H.,Benningshof, Jorg C. J.,Wegmann, Volker,Bank, Ruud A.,Te Koppele, Johan M.,Brussee, Johannes,Van der Gen, Arne
, p. 1673 - 1676 (2007/10/03)
A new synthetic route to reduced collagen crosslinks (LNL and HLNL) is described in this report. It enables an enantioselective synthesis of LNL. HLNL was obtained as a mixture of two diastereoisomers. This method also provides the possibility to introduce radio-labels during the synthesis.
